Dong Wei-Chong, Guo Jia-Liang, Wu Xi-Kun, Zhao Meng-Qiang, Li Hao-Ran, Zhang Zhi-Qing, Jiang Ye
Department of Pharmaceutical Analysis, School of Pharmacy, Hebei Medical University, Shijiazhuang, China.
Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Front Pharmacol. 2021 Apr 29;12:636975. doi: 10.3389/fphar.2021.636975. eCollection 2021.
High-dose methotrexate (HD-MTX) can be highly effective as well as extremely toxic. Many drug molecules can bind to plasma proteins to different extents , whereas only the free drug can reach the site of action to exert a pharmacological effect and cause toxicity. However, free MTX concentrations in plasma have not been reported. Traditional analyses of free drugs are both cumbersome and inaccurate. We collected 92 plasma samples from 52 children diagnosed with ALL or NHL or other lymphomas that were treated with HD-MTX. The hollow fiber centrifugal ultrafiltration (HFCF-UF) was used to prepare plasma samples for analysis of the free MTX concentration. Protein precipitation was employed to measure the total MTX concentration. The HFCF-UF is a simple method involving a step of ordinary centrifugation; the validation parameters for the methodological results were satisfactory and fell within the acceptance criteria. A linearity coefficient of 0.910 was obtained for the correlation between the free and total MTX plasma concentrations in 92 plasma samples. However, the free and total MTX concentrations was only weakly correlated in 16 clinical plasma specimens with total MTX concentrations >2 μmol L ( = 0.760). Both the free and total MTX concentrations at 42 h were negatively correlated with the creatinine clearance (CCr) level ( = 0.023, = -0.236 for total MTX and = 0.020, = -0.241for free MTX, respectively). The free MTX concentration could not be accurately estimated from the total MTX concentration for patients with high MTX levels which are conditions under which toxic reactions are more likely to occur. High plasma MTX levels could become a predictor of the occurrence of MTX nephrotoxicity to draw people's attention. The proposed HFCF-UF method is a simple and accurate way to evaluate efficacy and toxicity in clinical therapeutic drug monitoring.
大剂量甲氨蝶呤(HD-MTX)疗效显著,但毒性极强。许多药物分子能不同程度地与血浆蛋白结合,而只有游离药物才能到达作用部位发挥药理作用并产生毒性。然而,血浆中游离甲氨蝶呤的浓度尚未见报道。传统的游离药物分析方法既繁琐又不准确。我们收集了52例诊断为急性淋巴细胞白血病(ALL)、非霍奇金淋巴瘤(NHL)或其他淋巴瘤且接受HD-MTX治疗的儿童的92份血浆样本。采用中空纤维离心超滤(HFCF-UF)法制备用于分析游离甲氨蝶呤浓度的血浆样本。采用蛋白沉淀法测定总甲氨蝶呤浓度。HFCF-UF法是一种简单的方法,仅涉及一步普通离心;方法学结果的验证参数令人满意,且在可接受标准范围内。92份血浆样本中游离甲氨蝶呤与总甲氨蝶呤血浆浓度的相关性线性系数为0.910。然而,在16份总甲氨蝶呤浓度>2 μmol/L的临床血浆标本中,游离甲氨蝶呤与总甲氨蝶呤浓度仅呈弱相关(r = 0.760)。42小时时游离甲氨蝶呤和总甲氨蝶呤浓度均与肌酐清除率(CCr)水平呈负相关(总甲氨蝶呤r = 0.023,r = -0.236;游离甲氨蝶呤r = 0.020,r = -0.241)。对于甲氨蝶呤水平较高且更易发生毒性反应的患者,无法根据总甲氨蝶呤浓度准确估算游离甲氨蝶呤浓度。高血浆甲氨蝶呤水平可能成为甲氨蝶呤肾毒性发生的预测指标,值得关注。所提出的HFCF-UF法是临床治疗药物监测中评估疗效和毒性的一种简单而准确的方法。